Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)
Titel:
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)
Auteur:
Simpson, Eric Fernández-Peñas, Pablo de Bruin-Weller, Marjolein Lio, Peter A. Chu, Chia-Yu Ezzedine, Khaled Agell, Helena Casillas, Marta Ding, Yuxin Yang, Fan Emily Pierce, Evangeline Bieber, Thomas